Literature DB >> 22928925

Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex.

Rogelio de J Treviño-Rangel1, J Gerardo González, Gloria M González.   

Abstract

Candida parapsilosis is considered as an important emerging fungal pathogen and was recently found to be a complex that include three species, i.e., Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis. The aim of this study was to determine the in vitro aspartyl proteinase, phospholipase, esterase and hemolysin activities of 65 clinical isolates of the C. parapsilosis complex, which had been previously identified by RFLP-BanI analysis. Of the enzymes evaluated, aspartyl proteinase was the least produced by the C. parapsilosis species complex. Phospholipase and esterase were strongly expressed by C. orthopsilosis (67% of isolates), while 10% and 13% of C. parapsilosis sensu stricto isolates were strong producers, respectively, of these two enzymes. In contrast, high production of both enzymes was not detected in C. metapsilosis. Hemolysin activity was significantly more abundant in C. orthopsilosis (87%) than C. parapsilosis sensu stricto (67%). Overall, C. orthopsilosis isolates were statistically associated with the production of hemolysins (P= 0.048) and phospholipases (P< 0.0001) compared to isolates of C. parapsilosis sensu stricto or C. metapsilosis. Furthermore, a statistical association was found between isolates recovered from blood and phospholipase production (P= 0.017). The distribution of isolates obtained from blood was 30% of C. parapsilosis sensu stricto, 67% of C. orthopsilosis and 20% of C. metapsilosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22928925     DOI: 10.3109/13693786.2012.712724

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  11 in total

Review 1.  How much do we know about hemolytic capability of pathogenic Candida species?

Authors:  Márcia C Furlaneto; Helena P Góes; Hugo F Perini; Renan C Dos Santos; Luciana Furlaneto-Maia
Journal:  Folia Microbiol (Praha)       Date:  2018-01-15       Impact factor: 2.099

Review 2.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

3.  Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.

Authors:  Beatriz Virgínia da Silva; Larissa Beatriz Silva; Diego Batista Carneiro de Oliveira; Paulo Roberto da Silva; Kennio Ferreira-Paim; Leonardo Euripides Andrade-Silva; Mario León Silva-Vergara; Anderson Assunção Andrade
Journal:  Mycopathologia       Date:  2015-07-03       Impact factor: 2.574

4.  Hemolytic factor production by clinical isolates of Candida species.

Authors:  Daniel Favero; Luciana Furlaneto-Maia; Emanuele J G França; Helena Peggau Góes; Marcia Cristina Furlaneto
Journal:  Curr Microbiol       Date:  2013-09-19       Impact factor: 2.188

5.  Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.

Authors:  Sara Gago; Rocío García-Rodas; Isabel Cuesta; Emilia Mellado; Ana Alastruey-Izquierdo
Journal:  Virulence       Date:  2013-11-05       Impact factor: 5.882

6.  First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern.

Authors:  Rogelio de J Treviño-Rangel; José F Espinosa-Pérez; Hiram Villanueva-Lozano; Alexandra M Montoya; Angel Andrade; Alexandro Bonifaz; Gloria M González
Journal:  Folia Microbiol (Praha)       Date:  2018-02-27       Impact factor: 2.099

7.  Identification and differentiation of Candida parapsilosis complex species by use of exon-primed intron-crossing PCR.

Authors:  Xiaobo Feng; Zengbin Wu; Bo Ling; Shuming Pan; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

8.  Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.

Authors:  Sourour Neji; Ines Hadrich; Houaida Trabelsi; Salma Abbes; Fatma Cheikhrouhou; Hayet Sellami; Fattouma Makni; Ali Ayadi
Journal:  J Biomed Sci       Date:  2017-09-04       Impact factor: 8.410

9.  Members of the Candida parapsilosis Complex and Candida albicans are Differentially Recognized by Human Peripheral Blood Mononuclear Cells.

Authors:  Eine Estrada-Mata; María J Navarro-Arias; Luis A Pérez-García; Erika Mellado-Mojica; Mercedes G López; Katalin Csonka; Attila Gacser; Héctor M Mora-Montes
Journal:  Front Microbiol       Date:  2016-01-13       Impact factor: 5.640

10.  Evaluation of Exoenzyme Activities, Biofilm Formation, and Co-hemolytic Effect in Clinical Isolates of Candida parapsilosis Species Complex.

Authors:  Keyvan Pakshir; Mostafa Ravandeh; Hossein Khodadadi; Mohamad Motamedifar; Kamiar Zomorodian; Saeideh Alipour
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.